Bioactivity Of Neuropeptides
$0Z01FY2002ESNIH
Environmental Health Sciences
Investigators
Linked publications & trials
Paper 22214283Paper 19642675Paper 19576206Paper 18680274Paper 18571706Paper 18468445Paper 18311909Paper 18178091Paper 18069089Paper 18045209Paper 17851080Paper 17826995Paper 17626793Paper 17497839Paper 17339114Paper 17142049Paper 16949282Paper 16942040Paper 16942034Paper 16789756Paper 16782179Paper 16759107Paper 16755061Paper 16366592Paper 16335927Paper 16141586Paper 16107162Paper 15713427Paper 15664820Paper 15658871Paper 15588089Paper 15267245Paper 15214786Paper 15115401Paper 14718580Paper 14642588Paper 12852751Paper 12670649
Abstract
Summary of Work: The pharmacological and physiological activity of recently developed opioid analogues were determined in mice. The bioactivity profile paralled that of the in vitro pharmacological data and reflected the receptor binding affinity (see previous projects for details). Some synthetic analogues which exhibited agonism were weaker than the control substances (deltorphin for delta or morphine for mu receptors); however, some were substantially better (2- to 25-fold) than morphine in generating analgesia using standard testing procedures. In fact, these compounds are under patent application in Japan and disclosure at this time would jepardize that process.
View original record on NIH RePORTER →